Motor impairment Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Motor impairment clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

A Story for Pepper & Nao

Children and Adolescents With Neuromotor Impairment
IRCCS Fondazione Stella Maris80 enrolled3 locationsNCT06797050
Recruiting

CSF Protein Markers as Prognostic Indicators of the Response to CSF Shunt in Normotensive Hydrocephalus

Beta-amiloid and Phospho-tau Proteins in CSFVentricular Size After CSF ShuntCognitive Impairment and CSF Shunt+1 more
University of Valencia150 enrolled2 locationsNCT05915000
Recruiting

AI-based Model for Rehabilitation Engagement and Motor Performance Evaluation in Pediatric Patients

Neuromotor Impairments
IRCCS Eugenio Medea40 enrolled1 locationNCT06993389
Recruiting
Not Applicable

Clinical Impacts of Structured Robotic Gait Training Programs

Walking ImpairmentNeuromotor Impairments
University of Calgary120 enrolled1 locationNCT07405450
Recruiting

The FBRI VTC Neuromotor Research Clinic

AutismCerebral PalsyAcquired Brain Injury+4 more
Virginia Polytechnic Institute and State University500 enrolled1 locationNCT03325946
Recruiting

"Healthcare APPlication for Children and Young People With Neuromotor Disabilities": a Digital Tool to Promote Integrated Pediatric Rehabilitation Care for Children and Young People With Disabilities and Their Families: a Mixed-methods Usability-acceptability-impact Study (HAPPY)

Children and Adolescents With Neuromotor ImpairmentChildren and Youth With Special Healthcare Needs
University Hospital, Brest20 enrolled1 locationNCT07307950
Recruiting
Not Applicable

PT for Montana Children With NMD Using Hippotherapy and the Equine Environment

Neuromotor Impairments
University of Montana24 enrolled1 locationNCT06887647
Recruiting
Not Applicable

Effectiveness of Active Exploration of Simulated Textures for Sensorimotor Recovery

StrokeRehabilitationSensorimotor Impairment Affecting the Upper Limb+2 more
Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health20 enrolled1 locationNCT06962397
Recruiting
Not Applicable

Multicenter Study That Offers New Solutions for Paediatric Rehabilitation by Proposing a Rehabilitation Plan Based on Each Child's Needs Using New Technological and Robotic Devices, Combined Among Them.

Neuromotor Impairments
IRCCS Fondazione Stella Maris194 enrolled6 locationsNCT06666829
Recruiting

Evaluation of the psychoneuroimmunological state of healthy humans following intramuscular injection of the influenza (FluQuadriTM) vaccine, a two-way crossover double-blinded placebo-controlled trial

Immune responsesPsychomotor impairment
Australian Government, Department of Defence (Defence Science and Technology Group, DMTC)40 enrolled1 locationACTRN12623000650695